Molecular Basis and Current Insights of Atypical Rho Small GTPase in Cancer

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2024 Jan 18

PMID 38236467

Authors

Hua Huang

Sijia Wang

Yifei Guan

Jing Ren

Xinhui Liu

Affiliations

Soon will be listed here.

Abstract

Atypical Rho GTPases are a subtype of the Rho GTPase family that are involved in diverse cellular processes. The typical Rho GTPases, led by RhoA, Rac1 and Cdc42, have been well studied, while relative studies on atypical Rho GTPases are relatively still limited and have great exploration potential. With the increase in studies, current evidence suggests that atypical Rho GTPases regulate multiple biological processes and play important roles in the occurrence and development of human cancers. Therefore, this review mainly discusses the molecular basis of atypical Rho GTPases and their roles in cancer. We summarize the sequence characteristics, subcellular localization and biological functions of each atypical Rho GTPase. Moreover, we review the recent advances and potential mechanisms of atypical Rho GTPases in the development of multiple cancers. A comprehensive understanding and extensive exploration of the biological functions of atypical Rho GTPases and their molecular mechanisms in tumors will provide important insights into the pathophysiology of tumors and the development of cancer therapeutic strategies.

Citing Articles

Cutaneous squamous cell carcinoma-derived exosomal MicroRNA-31 acts as an oncogene by targeting the tumor suppressor RhoBTB1.

Mu Y, Lian C, Chen X, Yang X, Li D, Zhang Y Arch Dermatol Res. 2024; 317(1):114.

PMID: 39673615 DOI: 10.1007/s00403-024-03558-0.

References

Rojas A, Fuentes G, Rausell A, Valencia A . The Ras protein superfamily: evolutionary tree and role of conserved amino acids. J Cell Biol. 2012; 196(2):189-201. PMC: 3265948. DOI: 10.1083/jcb.201103008. View

Freymann D, Keenan R, Stroud R, Walter P . Functional changes in the structure of the SRP GTPase on binding GDP and Mg2+GDP. Nat Struct Biol. 1999; 6(8):793-801. DOI: 10.1038/11572. View

Donovan S, Shannon K, Bollag G . GTPase activating proteins: critical regulators of intracellular signaling. Biochim Biophys Acta. 2002; 1602(1):23-45. DOI: 10.1016/s0304-419x(01)00041-5. View

Seabra M . Membrane association and targeting of prenylated Ras-like GTPases. Cell Signal. 1998; 10(3):167-72. DOI: 10.1016/s0898-6568(97)00120-4. View

Takai Y, Kaibuchi K, Kikuchi A, Kawata M . Small GTP-binding proteins. Int Rev Cytol. 1992; 133:187-230. DOI: 10.1016/s0074-7696(08)61861-6. View

Heasman S, Ridley A . Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol. 2008; 9(9):690-701. DOI: 10.1038/nrm2476. View

Mouawad F, Tsui H, Takano T . Role of Rho-GTPases and their regulatory proteins in glomerular podocyte function. Can J Physiol Pharmacol. 2013; 91(10):773-82. DOI: 10.1139/cjpp-2013-0135. View

Matsuda J, Asano-Matsuda K, Kitzler T, Takano T . Rho GTPase regulatory proteins in podocytes. Kidney Int. 2020; 99(2):336-345. DOI: 10.1016/j.kint.2020.08.035. View

Sahai E, Marshall C . RHO-GTPases and cancer. Nat Rev Cancer. 2003; 2(2):133-42. DOI: 10.1038/nrc725. View

10.

Rossman K, Der C, Sondek J . GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol. 2005; 6(2):167-80. DOI: 10.1038/nrm1587. View

11.

Aspenstrom P . Fast-cycling Rho GTPases. Small GTPases. 2017; 11(4):248-255. PMC: 7549678. DOI: 10.1080/21541248.2017.1391365. View

12.

Li X, Bu X, Lu B, Avraham H, Flavell R, Lim B . The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol Cell Biol. 2002; 22(4):1158-71. PMC: 134637. DOI: 10.1128/MCB.22.4.1158-1171.2002. View

13.

Foster R, Hu K, Lu Y, Nolan K, Thissen J, Settleman J . Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation. Mol Cell Biol. 1996; 16(6):2689-99. PMC: 231259. DOI: 10.1128/MCB.16.6.2689. View

14.

Sugawara R, Ueda H, Honda R . Structural and functional characterization of fast-cycling RhoF GTPase. Biochem Biophys Res Commun. 2019; 513(2):522-527. DOI: 10.1016/j.bbrc.2019.04.018. View

15.

Aspenstrom P, Ruusala A, Pacholsky D . Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases. Exp Cell Res. 2007; 313(17):3673-9. DOI: 10.1016/j.yexcr.2007.07.022. View

16.

Binti Ahmad Mokhtar A, B M Ahmed S, Darling N, Harris M, Mott H, Owen D . A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases. Biochemistry. 2021; 60(19):1533-1551. PMC: 8253491. DOI: 10.1021/acs.biochem.1c00120. View

17.

Haga R, Ridley A . Rho GTPases: Regulation and roles in cancer cell biology. Small GTPases. 2016; 7(4):207-221. PMC: 5129894. DOI: 10.1080/21541248.2016.1232583. View

18.

Blom M, Reis K, Heldin J, Kreuger J, Aspenstrom P . The atypical Rho GTPase RhoD is a regulator of actin cytoskeleton dynamics and directed cell migration. Exp Cell Res. 2017; 352(2):255-264. DOI: 10.1016/j.yexcr.2017.02.013. View

19.

Jaiswal M, Fansa E, Dvorsky R, Ahmadian M . New insight into the molecular switch mechanism of human Rho family proteins: shifting a paradigm. Biol Chem. 2012; 394(1):89-95. DOI: 10.1515/hsz-2012-0207. View

20.

Vega F, Ridley A . Rho GTPases in cancer cell biology. FEBS Lett. 2008; 582(14):2093-101. DOI: 10.1016/j.febslet.2008.04.039. View